AI innovation “Sturgeon” transforms classification of central nervous system malignancies

Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of CNS malignancies.

Kamala Harris, endorsed by Biden to replace him, is left of the president on health care

WASHINGTON — President Biden is ending his bid for a second term in office and backing Vice President Kamala Harris to take the nomination, he

July 21, 2024

Madrigal plans to solidify Rezdiffra’s position in MASH despite start being slower than expected

In March 2024, Madrigal Pharmaceuticals had a breakthrough moment when, after years of research and anticipation, the US Food and Drug Administration (FDA) granted approval

August 13, 2024

Marinus parts ways with 20% of its workforce – Pharmaceutical Technology

Oral ganaxolone, marketed under the brand name Ztalmy, first received FDA approval to treat seizures associated with CDKL5 deficiency disorder in March 2022. Credits: Tunatura/Shutterstock.com

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.